| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Other
|
TXT
|
Joanna Achinger-Kawecka
|
|||||
| GSE73782 |
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [Hi-C]
|
|
13 |
|
Joanna Achinger-Kawecka | Apr 04, 2016 | ||
| GSE118712 |
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [Hi-C]
|
|
9 |
|
Joanna Achinger-Kawecka | Dec 11, 2019 | ||
| GSE118716 |
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer
|
40 | Joanna Achinger-Kawecka | Dec 11, 2019 | ||||
| GSE130916 |
Deregulation of the three-dimensional epigenome in endocrine resistant breast cancer
|
|
6 |
|
Joanna Achinger-Kawecka | Dec 11, 2019 | ||
| GSE171071 |
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [HiC]
|
|
6 |
|
Joanna Achinger-Kawecka | Dec 12, 2021 | ||
| GSE171072 |
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [PCHiC]
|
|
6 |
|
Joanna Achinger-Kawecka | Dec 12, 2021 | ||
| GSE171074 |
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
|
88 |
|
Joanna Achinger-Kawecka | Dec 12, 2021 | |||
| GSE216987 |
Decitabine treatment reveals a functional role of DNA hypomethylation in organising enhancer-promoter interactions [Promoter Capture Hi-C]
|
|
8 |
|
Joanna Achinger-Kawecka | Aug 08, 2023 | ||
| GSE216989 |
Decitabine treatment reveals a functional role of DNA hypomethylation in organising enhancer-promoter interactions
|
24 |
|
Joanna Achinger-Kawecka | Aug 07, 2023 |
